Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids.
Bartalena L, Manetti L, Tanda ML, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A, Marcocci C. Bartalena L, et al. Among authors: mazzi b. Clin Endocrinol (Oxf). 2000 May;52(5):647-51. doi: 10.1046/j.1365-2265.2000.00988.x. Clin Endocrinol (Oxf). 2000. PMID: 10792346
Orbital radiotherapy for Graves' ophthalmopathy.
Bartalena L, Marcocci C, Tanda ML, Rocchi R, Mazzi B, Barbesino G, Pinchera A. Bartalena L, et al. Among authors: mazzi b. Thyroid. 2002 Mar;12(3):245-50. doi: 10.1089/105072502753600223. Thyroid. 2002. PMID: 11952048 Review.
Long-term safety of orbital radiotherapy for Graves' ophthalmopathy.
Marcocci C, Bartalena L, Rocchi R, Marinò M, Menconi F, Morabito E, Mazzi B, Mazzeo S, Sartini MS, Nardi M, Cartei F, Cionini L, Pinchera A. Marcocci C, et al. Among authors: mazzi b. J Clin Endocrinol Metab. 2003 Aug;88(8):3561-6. doi: 10.1210/jc.2003-030260. J Clin Endocrinol Metab. 2003. PMID: 12915636
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A. Marcocci C, et al. Among authors: mazzi b. J Clin Endocrinol Metab. 2001 Aug;86(8):3562-7. doi: 10.1210/jcem.86.8.7737. J Clin Endocrinol Metab. 2001. PMID: 11502779 Clinical Trial.
Graves' ophthalmopathy and 131I therapy.
Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A. Marcocci C, et al. Among authors: mazzi b. Q J Nucl Med. 1999 Dec;43(4):307-12. Q J Nucl Med. 1999. PMID: 10731781 Review.
Current medical management of Graves ophthalmopathy.
Marcocci C, Bartalena L, Marinò M, Rocchi R, Mazzi B, Menconi F, Morabito E, Pinchera A. Marcocci C, et al. Among authors: mazzi b. Ophthalmic Plast Reconstr Surg. 2002 Nov;18(6):402-8. doi: 10.1097/00002341-200211000-00003. Ophthalmic Plast Reconstr Surg. 2002. PMID: 12439051 Review. No abstract available.
Orbital decompression in graves' ophthalmopathy by medial and lateral wall removal.
Sellari-Franceschini S, Berrettini S, Santoro A, Nardi M, Mazzeo S, Bartalena L, Mazzi B, Tanda ML, Marcocci C, Pinchera A. Sellari-Franceschini S, et al. Among authors: mazzi b. Otolaryngol Head Neck Surg. 2005 Aug;133(2):185-9. doi: 10.1016/j.otohns.2005.02.006. Otolaryngol Head Neck Surg. 2005. PMID: 16087011
76 results